Urolume endourethral prosthesis for the treatment of urethral stricture disease: Long-term results of the North American multicenter urolume trial

To evaluate the long-term results of the UroLume endourethral prosthesis for the treatment of recurrent bulbar urethral strictures. In a multicenter, prospective study 175 patients with recurrent bulbar urethral strictures were enrolled in a Food and Drug Administration (PDA) trial of the UroLume en...

Full description

Saved in:
Bibliographic Details
Published in:Urology (Ridgewood, N.J.) N.J.), 1995-05, Vol.45 (5), p.846-856
Main Authors: Badlani, Gopal H., Press, Scott M., Defalco, Alfred, Oesterling, Joseph E., Smith, Arthur D.
Format: Article
Language:English
Subjects:
Adolescent
Adult
Aged
Aged, 80 and over
Canada
Endoscopes
Follow-Up Studies
Humans
Incidence
Male
Middle Aged
Postoperative Complications - epidemiology
Prospective Studies
Prostheses and Implants
Prosthesis Design
Prosthesis Failure
Recurrence
Stents
Time Factors
Treatment Outcome
United States
Urethral Stricture - physiopathology
Urethral Stricture - surgery
Urodynamics
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:To evaluate the long-term results of the UroLume endourethral prosthesis for the treatment of recurrent bulbar urethral strictures. In a multicenter, prospective study 175 patients with recurrent bulbar urethral strictures were enrolled in a Food and Drug Administration (PDA) trial of the UroLume endourethral prosthesis. One hundred thirty-nine patients were available for follow-up at 1 year, and 81 patients were available for follow-up at 2 years. Clinically and statistically significant results were seen at 1 year and sustained at 2 years. Re-treatment rate was down from 75.2% preinsertion to 14.3% 1 year postinsertion of the prosthesis. Explantation was required in only 3% of patients. Based on these and European data, the UroLume endourethral prosthesis offers a significant advantage over the currently available treatments for recurrent bulbar urethral strictures.
ISSN:0090-4295
1527-9995
DOI:10.1016/S0090-4295(99)80093-4